| COVID-19 vaccines: how to ensure Africa has access #MMPMID33024330Nkengasong JN; Ndembi N; Tshangela A; Raji TNature 2020[Oct]; 586 (7828): 197-199 PMID33024330show ga
ä|*Developed Countries[MESH]|*Developing Countries[MESH]|*International Cooperation[MESH]|Acquired Immunodeficiency Syndrome/epidemiology/mortality[MESH]|Africa/epidemiology[MESH]|Animals[MESH]|Anti-HIV Agents/history/supply & distribution[MESH]|COVID-19[MESH]|COVID-19 Testing[MESH]|COVID-19 Vaccines[MESH]|Clinical Laboratory Techniques[MESH]|Coronavirus Infections/diagnosis/economics/*epidemiology/*prevention & control[MESH]|Global Health[MESH]|History, 20th Century[MESH]|History, 21st Century[MESH]|Humans[MESH]|Influenza Vaccines/history/supply & distribution[MESH]|Pandemics/economics/*prevention & control[MESH]|Pneumonia, Viral/diagnosis/economics/*epidemiology/*prevention & control[MESH]|United States/epidemiology[MESH]|Viral Vaccines/adverse effects/economics/*supply & distribution[MESH]
DeepDyve Pubget Overpricing |
|